*At the time of publication, the U.S. Food & Drug Administration has cleared ultrasound contrast agents only for use in LVO. Check the current regulation for the country in which you are using this system for contrast agent clearance
** This feature should be utilized according to the ASE Consensus Statement "Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force, Endorsed by the Society for Vascular Medicine”
*** Based on Dr. Jim Stein’s patented algorithm:
Stein, JH, Fraizer, MC, Aeschlimann SE, Nelson-Worel J, McBride PE, Douglas PS. Vascular age: integrating carotid intima-media thickness measurements with
global coronary risk assessment. Clin Cardiol 2004; 27:388-92.
M